Association between serum amyloid A proteins and coronary artery disease: Evidence from two distinct arteriosclerotic processes

Circulation

Volumn 96, Issue 9, 1997, Pages 2914-2919

  Fyfe, Alistair I ^a   Rothenberg, L S ^b   DeBeer, Frederick C ^c   Cantor, Rita M ^d   Rotter, Jerome I ^d   Lusis, Aldons J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Amyloid; Apolipoproteins; Atherosclerosis; Cholesterol; Coronary disease; Transplantation

Indexed keywords

C REACTIVE PROTEIN; SERUM AMYLOID A;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; PROTEIN FAMILY; REGRESSION ANALYSIS;

EID: 0030685738     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.9.2914     Document Type: Article

References (42)

1. Malle E, Steinmetz A, Raynes JG. Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis. 1993;102:131-146.
2. Badolato R, Wang JM, Murphy WJ, Lloyd AR, Michiel DF, Bausserman LL, Kelvin DJ, Oppenheim JJ. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med. 1994;180:203-209.
3. Qiao J-H, Xie P-Z, Fishbein MC, Kreuzer J, Drake TA Demer LL, Lusis AJ. Pathology of atheromatous lesions in inbred and genetically engineered mice: genetic determination of arterial calcification. Arterioscler Thromb. 1994;14:1480-1497.
4. Meek RL, Urieli-Shoval S, Benditt EP. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A. Proc Natl Acad Sci U S A. 1994;91:3186-3190.
5. Liao F, Lusis AJ, Berliner JA, Fogelman AM, Kindy M, deBeer MC, deBeer FC. Serum amyloid A protein family: differential induction by oxidized lipids in mouse strains. Arterioscler Thromb. 1994;14:1475-1479.
6. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
7. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
8. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. Prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;331:417-424.
9. Qiao J-H, Castellani LW, Fishbein MC, Lusis AJ. Immune-complex-mediated vasculitis increased coronary artery lipid accumulation in autoimmune-prone MRL mice. Arterioscler Thromb. 1993;13:932-940.
10. κB like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest. 1993;91:2572-2579.
11. Tsakraklides VG, Blieden IC, Edwards JE. Coronary atherosclerosis and myocardial infarction associated with systemic lupus erythematosus. Am Heart J. 1974;87:637-641.
12. Wolf F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994;37:481-494.
13. Gidding S, Cabana V, Getz G, Rowley A. Serum amyloid A, HDL cholesterol, and apolipoprotein A1 in Kawasaki disease. Circulation. 1993;88(suppl II):11-12. Abstract.
14. Fyfe AI. Transplant atherosclerosis: the clinical syndrome, pathogenesis and possible role as a model of spontaneous atherosclerosis. Can J Cardiol. 1992;8:509-519.
15. Ogata F, Kohoda Y, Suzuki M, Hirasawa Y. High levels of serum amyloid A persist for a long time after kidney transplantation. Nephron. 1990;55:216-217.
16. Billingham ME, Cary NRB, Hammond ME, Kemnitz J, Marboe C, McAllister HA, Snovar DC, Winters GL, Zerbe A. A working formula for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Transplant. 1990;9:587-592.
17. Bu X-D, Warden CH, Xia Y-R, DeMeester C, Puppione DL, Teruya S, Lokensgard B, Daneshmand S, Brown J, Gray RJ, Rotter JI, Lusis AJ. Linkage analysis of the genetic determinants of high density lipoprotein concentration and composition: evidence for involvement of the apolipoprotein A-II and cholesterol ester transfer protein loci. Hum Genet. 1994;93:639-648.
18. Rotter JI, Bu X, Cantor RM, Warden CH, Brown J, Gray RJ, Blanche PJ, Krauss RM, Lusis AJ. Multilocus genetic determinants of LDL particle size in coronary artery disease families. Am J Hum Genet. 1996;58:585-594.
19. DeMeester CA, Bu X, Gray RJ, Lusis AJ, Rotter JI. Genetic variation in lipoprotein(a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein(a) gene locus. Am J Hum Genet. 1995;56:287-293.
20. Warden CH, Daluiski A, Bu X, Purcell-Huynh DA, DeMeester C, Shieh B-H, Puppione DL, Gray RM, Reaven GM, Chen Y-DI, Rotter JI, Lusis AJ. Evidence of linkage of the apolipoprotein AII locus to plasma apolipoprotein AII and free fatty acid levels in both mice and humans. Proc Natl Acad Sci U S A. 1993;90:10886-10890.
21. McDonald TL, Weber A, Smith JW. A monoclonal antibody sandwich immunoassay for serum amyloid A (SAA) protein. J Immunol Methods. 1991;144:149-155.
22. DeBeer MC, Beach CM, Shedlofsky SI, deBeer FC. Identification of a novel serum amyloid A protein (SAA) in BALB/c mice. Biochem J. 1991;180:45-49.
23. Whitehead AD, deBeer MC, Steel DM, Ritz M, Lelias JM, Lane WS, deBeer FC. Identification of novel members of the serum amyloid A protein (SAA) superfamily as constitutive apolipoproteins of high density lipoprotein. J Biol Chem. 1992;295:677-687.
24. S.A.G.E. Statistical analyses for genetic epidemiology; computer program package available from the Department of Biometry and Genetics, LSU Medical Center. Release 2.2, New Orleans, La; 1994.
25. Strachan AF, Brandt WF, Woo P, van der Westhuyzen DR, Coetzee CA, deBeer MC, Shepard EG, deBeer FC. Evidence that the six major isoforms of human serum amyloid A protein are coded for by three genes at two genetic loci. J Biol Chem. 1989;264:18368-18373.
26. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms: oxidation, inflammation, and genetics. Circulation. 1995;91:2488-2496.
27. Coetzee GA, Strachan AF, van der Westhuyzen DR, Hoppe HC, Jeenah MS, deBeer FC. Serum amyloid A-containing human high density lipoprotein 3: density, size and apolipoprotein composition. J Biol Chem. 1986;261:9644-9651.
28. Kumon Y, Suehiro T, Ikeda Y, Yoshida K, Hashimoto K, Ohno F. Influence of serum amyloid A protein on high-density lipoprotein in chronic inflammatory disease. Clin Biochem. 1993;26:505-511.
29. McKnight GL, Reasoner J, Gilbert T, Sundquist KO, Hokland B, McKernan PA, Champagne J, Johnson CJ, Bailey MC, Holly R, O'Hara PJ, Oram JF. Cloning and expression of a cellular high density lipoprotein-binding protein that is up-regulated by cholesterol loading of cells. J Biol Chem. 1992;267:12131-12141.
30. Warden CH, Hedrick CC, Qiao J-H, Castellani LW, Lusis AJ. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science. 1993;261:469.
31. Chancerelle Y, Lorgeril M, Viret R, Chiron B, Dureau G, Renaud S, Kerfonou J-F. Increased lipid peroxidation in cyclosporine-treated heart transplant recipients. Am J Cardiol. 1991;68:813-816.
32. Kisilevsky R, Subrahmanyan L. Serum amyloid A changes high density lipoprotein's cellular affinity: a clue to serum amyloid A's principal function. Lab Invest. 1992;66:778-785.
33. Fyfe AI, Daly PA, Galligan L, Pire L, Feindel CM, Cardella CJ. Coronary sinus sampling of cytokines after cardiac transplantation: evidence for macrophage activation and interleukin 4 production within the graft. J Am Coll Cardiol. 1993;21:171-176.
34. Smith JW, McDonald TL. Production of serum amyloid A and C-reactive protein by HepG2 cells stimulated with combinations of cytokines or monocyte conditioned media: the effects of prednisone. Clin Exp Immunol. 1992;90:783-789.
35. Valantine H, Pinto FJ, St. Goar F, Alderman EL, Popp RL. Intra-coronary ultrasound imaging in heart transplant recipients: the Stanford experience. J Heart Lung Transplant. 1992;11:S60-S64.
36. Kobashigawa JA, Gleeson MP, Stevenson LW, Kawata N, Moriguchi JD, Hamilton MH, Hage A, Drinkwater DC, Laks H. Late steroid weaning in cardiac transplant patients is not associated with an increase in transplant coronary artery disease. J Heart Lung Transplant. 1994;13:S48. Abstract.
37. Radley-Smith RC, Yacoub M. Long term results of pediatric heart transplantation. J Heart Lung Transplant. 1992;11:S277-S281.
38. Koachi R, Takebayashi S, Hiroki T, Nobuyoshi M. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. Circulation. 1985;71:709-716.
39. Sernini GG, Abbate R, Gori AM, Attanasio M, Martini F, Giusti B, Dabizzi P, Poggesi L, Modesti PA, Francesco T, Rostagno C, Boddi M, Gensini F. Transient lymphocyte activation is responsible for the instability of angina. Circulation. 1992;86:790-797.
40. Mazzone A, De Servi S, Ricevuti G, Mazzucchelli I, Fossati G, Pasotti D, Bramucci E, Angoli L, Marsico F, Specchia G, Notario A. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation. 1993;88: 358-363.
41. Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift R. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature. 1991;353:265-267.
42. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.